Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-24-002840

Chief Scientific Officer gave up 2,583 shares (to pay taxes)

  • Chief Scientific Officer acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Monahan Joseph Chief Scientific Officer 2024-02-01 Option exercise +7,500 137,224 D
Monahan Joseph Chief Scientific Officer 2024-02-01 Shares withheld for taxes −2,583 $1.20 $3,100 134,641 D
Derivatives
Monahan Joseph Chief Scientific Officer 2024-02-01 Option exercise · Restricted Stock Unit −7,500 22,500 D
Monahan Joseph Chief Scientific Officer 2024-02-01 Grant or award · Employee Stock Option (Right to Buy) +206,500 206,500 D
Monahan Joseph Chief Scientific Officer 2024-02-01 Grant or award · Restricted Stock Units +59,000 59,000 D
Monahan Joseph Chief Scientific Officer 2024-02-01 Grant or award · Restricted Stock Units +147,500 147,500 D
Loading xslF345X05/doc4.xml…